Arcturus Therapeutics In... (ARCT)
Arcturus Therapeutics Statistics
Share Statistics
Arcturus Therapeutics has 27.12M shares outstanding. The number of shares has increased by 0.7% in one year.
| 27.12M |
| 0.7% |
| 0.12% |
| 98.49% |
| n/a |
| 21 |
| n/a |
Short Selling Information
The latest short interest is 5.41M, so 19.96% of the outstanding shares have been sold short.
| 5.41M |
| 19.96% |
| 30.88% |
| 11.82 |
Valuation Ratios
The PE ratio is -5.66 and the forward PE ratio is -3.97. Arcturus Therapeutics's PEG ratio is -0.03.
| -5.66 |
| -3.97 |
| 3.31 |
| 0.5 |
| 1.9 |
| -7.59 |
| -0.03 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Arcturus Therapeutics.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 4.67, with a Debt / Equity ratio of 0.12.
| 4.67 |
| 4.67 |
| 0.12 |
| -0.37 |
| -0.47 |
| 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $795,339.08 |
| $-465,178.16 |
| 174 |
| 0.4 |
| n/a |
Taxes
| -4K |
| 0% |
Stock Price Statistics
The stock price has increased by -59.87% in the last 52 weeks. The beta is 2.29, so Arcturus Therapeutics's price volatility has been higher than the market average.
| 2.29 |
| -59.87% |
| 11.48 |
| 16.5 |
| 54.97 |
| 449,069 |
Income Statement
In the last 12 months, Arcturus Therapeutics had revenue of 138.39M and earned -80.94M in profits. Earnings per share was -3.
| 138.39M |
| 134.84M |
| -95.67M |
| -80.94M |
| -77.4M |
| -80.94M |
| -3 |
Balance Sheet
The company has 237.03M in cash and 28.55M in debt, giving a net cash position of 208.48M.
| 237.03M |
| 28.55M |
| 208.48M |
| -448.81M |
| 331.79M |
| 229.38M |
Cash Flow
In the last 12 months, operating cash flow was -59.75M and capital expenditures -648K, giving a free cash flow of -60.4M.
| -59.75M |
| -648K |
| -60.4M |
| -2.24 |
Margins
Gross margin is 97.44%, with operating and profit margins of -69.13% and -58.49%.
| 97.44% |
| -69.13% |
| -58.49% |
| -58.49% |
| -55.93% |
| -69.13% |
| -43.64% |
Dividends & Yields
ARCT does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for ARCT is $52.5, which is 311.1% higher than the current price. The consensus rating is "Buy".
| $52.5 |
| 311.1% |
| Buy |
| 7 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Stock Splits
The last stock split was on Nov 16, 2017. It was a backward split with a ratio of 1:7.
| Nov 16, 2017 |
| backward |
| 1:7 |
Scores
| 0.61 |
| 2 |